☆ 4.6 Article

Is Lymphocyte C-Reactive Protein Ratio Useful for Predicting Survival in Patients with Non-Metastatic Soft Tissue Sarcoma?

CANCERS (2022)

Related references

Note: Only part of the references are listed.

Article Oncology

Absolute lymphocyte count is an independent predictor of survival in patients with metastatic renal cell carcinoma treated with nivolumab

Kosuke Ueda et al.

Summary: This study found that peripheral absolute lymphocyte count can predict the efficacy of nivolumab therapy in patients with metastatic renal cell carcinoma. Low absolute lymphocyte count before treatment was associated with shorter progression-free survival and overall survival, while an increase in absolute lymphocyte count one month after treatment was associated with better efficacy.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Association between absolute lymphocyte count and overall mortality in patients with surgically resected gastric cancer

Se Jun Park et al.

Summary: This study found that ever lymphopenia is an independent prognostic factor for overall mortality and recurrence in patients with potentially curable gastric cancer. Therefore, ALCs may be a biomarker for predicting the prognoses of patients with stage I-III gastric cancer who had curative gastrectomy.

KOREAN JOURNAL OF INTERNAL MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

Evaluation of Absolute Lymphocyte Count at Diagnosis and Mortality Among Patients With Localized Bone or Soft Tissue Sarcoma

Ryan Brewster et al.

Summary: This study suggests that an abnormally low absolute lymphocyte count at diagnosis is associated with higher mortality among patients with localized bone and soft tissue sarcoma, indicating lymphopenia may serve as a reliable prognostic biomarker. Potential mechanisms related to host immunity and overall survival include suppressed antitumor response and increased infectious complications, warranting further investigation.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Surgery

Could lymphocyte to C-reactive protein ratio predict the prognosis in patients with gastric cancer?

Yavuz Selim Angin et al.

Summary: The study revealed a correlation between preoperative low LCR value and advanced stage and prognosis of gastric cancer patients, showing the significant impact of LCR and NLR parameters on prognosis. Patients with LCR values above 193 had significantly longer survival times compared to those with lower LCR values.

ANZ JOURNAL OF SURGERY (2021)

Add to Collection

Article Oncology

Clinical Outcome in Soft Tissue Sarcoma Patients with Lung Metastasis Who Received Metastasectomy and/or Radiofrequency Ablation: Tokai Musculoskeletal Oncology Consortium Study

Tomoki Nakamura et al.

Summary: The study investigated the oncological outcomes of lung metastasectomy and/or radiofrequency ablation in patients with soft tissue sarcoma. Results showed that complete treatment for the initial metastasis improved post-metastatic survival rates, with tumor size and number being important variables for clinical decision-making. Patients with a smaller single metastasis had better post-metastasis survival rates compared to those with larger and multiple metastases. The 5-year post-metastatic survival rates were higher for patients with a smaller single metastasis.

CANCER MANAGEMENT AND RESEARCH (2021)

Add to Collection

Article Oncology

Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma

Norifumi Iseda et al.

Summary: The study found that preoperative lymphocyte-to-C-reactive protein ratio (LCR) is the most relevant indicator of recurrence-free survival (RFS) in patients with hepatocellular carcinoma (HCC). Patients with high LCR have better prognosis, which is closely related to the tumor microenvironment and immune status.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Surgery

Lymphocyte-to-C-Reactive Protein Ratio as a Novel Marker for Predicting Oncological Outcomes in Patients with Esophageal Cancer

Masashi Takeuchi et al.

Summary: The study revealed that the lymphocyte-to-C-reactive protein ratio (LCR) is a predictor of long-term outcomes for patients with esophageal cancer, and it is more accurate in predicting survival compared to other inflammatory markers.

WORLD JOURNAL OF SURGERY (2021)

Add to Collection

Article Surgery

Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer

Yoshinaga Okugawa et al.

ANNALS OF SURGERY (2020)

Add to Collection

Article Oncology

Circulating activated lymphocyte subsets as potential blood biomarkers of cancer progression

Ying-Yi Wang et al.

CANCER MEDICINE (2020)

Add to Collection

Article Oncology

Prediction of Soft Tissue Sarcoma from Clinical Characteristics and Laboratory Data

Taketsugu Fujibuchi et al.

CANCERS (2020)

Add to Collection

Article Oncology

The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study

T. Karantanos et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2019)

Add to Collection

Article Multidisciplinary Sciences

The value of C-reactive protein as an independent prognostic indicator for disease specific survival in patients with soft tissue sarcoma: A meta-analysis

Xiaolin Wang et al.

PLOS ONE (2019)

Add to Collection

Article Oncology

Neutrophil/lymphocyte ratio is associated with survival in synovial sarcoma

Dorian Yarih Garcia-Ortega et al.

SURGICAL ONCOLOGY-OXFORD (2018)

Add to Collection

Review Immunology

Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy

Pingyi Liu et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2018)

Add to Collection

Article Oncology

Lymphopenia and its association with survival in patients with locally advanced cervical cancer

Emily S. Wu et al.

GYNECOLOGIC ONCOLOGY (2016)

Add to Collection

Letter Hematology

Absolute lymphocyte count as a prognostic marker in newly diagnosed multiple myeloma patients

C. Suriu et al.

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2016)

Add to Collection

Article Oncology

Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma

Yi Que et al.

BMC CANCER (2015)

Add to Collection

Review Immunology

Tapping CD4 T Cells for Cancer Immunotherapy: The Choice of Personalized Genomics

Maurizio Zanetti

JOURNAL OF IMMUNOLOGY (2015)

Add to Collection

Article Oncology

The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas

Joanna Szkandera et al.

INTERNATIONAL JOURNAL OF CANCER (2014)

Add to Collection

Article Dermatology

Absolute lymphocyte count: A potential prognostic factor for Merkel cell carcinoma

Matthew E. Johnson et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)

Add to Collection

Article Medicine, General & Internal

Lymphopenia Predicts Poor Prognosis in Patients With Esophageal Squamous Cell Carcinoma

Ji-Feng Feng et al.

MEDICINE (2014)

Add to Collection

Article Oncology

The value of C-reactive protein and comorbidity in predicting survival of patients with high grade soft tissue sarcoma

Tomoki Nakamura et al.

EUROPEAN JOURNAL OF CANCER (2013)

Add to Collection

Article Oncology

The Combined Use of the Neutrophil-Lymphocyte Ratio and C-Reactive Protein Level as Prognostic Predictors in Adult Patients With Soft Tissue Sarcoma

Tomoki Nakamura et al.

JOURNAL OF SURGICAL ONCOLOGY (2013)

Add to Collection

Article Oncology

Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma

Tomoki Nakamura et al.

CANCER (2012)

Add to Collection

Review Multidisciplinary Sciences

Cancer immunotherapy comes of age

Ira Mellman et al.

NATURE (2011)

Add to Collection

Review Medicine, General & Internal

Medical progress: Soft-tissue sarcomas in adults

MA Clark et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Add to Collection

Article Oncology

Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy - An analysis of 1225 patients

GK Zagars et al.

CANCER (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.